Wireless Spinal Cord Stimulation for Chronic Pain
CompletedNot applicableNCT02514590
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to assess the effectiveness of the Stimwave Spinal Cord Stimulator (SCS) System for treatment of chronic pain
Study details
- Official title
- Multi-center, Prospective, Clinical Trial of Wireless Spinal Cord Stimulation in the Treatment of Chronic Pain
- Conditions
- Interventions
- Device: Freedom SCS System
- Sponsor
- Curonix LLC
- Collaborators
- The Cleveland Clinic; The Center for Clinical Research, Winston-Salem, NC; Anesthesia Pain Care Consultants, Tamarac, FL, USA; Precision Spine Care, Tyler, TX, USA; Nuvo Spine and Sports Institute & Ortho Regenerative Center, Encino, CA, USA; Compass Research LLC, Orlando, FL, USA; USC Spine, Keck hospital of USC, Los Angeles, CA, USA
- Start date
- 2016-07
- Primary completion
- 2019-01
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 7
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Subject is ≥ 18 years of age at time of informed consent; * Subjects have been diagnosed with chronic back or back and leg pain with an average VAS \> 5 (on a 10 scale) over the course of the last month for back pain based on baseline pain diary; * Subject diagnosis with chronic back or back and leg pain associated with FBSS refractory to conventional medical management for at least 12 months prior to enrollment; * Based on the medical opinion of the Principal Investigator, subject has a stable pain medication regiment; * Based on the medical opinion of the Principal Investigator, there is no evidence of anatomic abnormalities that could jeopardize the placement of the device or pose a hazard to the subject; * Based on the opinion of the Principal Investigator, subject is willing and able to operate the patient programmer, recharging equipment, diary and has the ability to undergo study assessments and provide accurate responses; * Based on the opinion of the implanter, subject is a good surgical subject for the implant procedure; * Subject is willing to undergo surgical implant procedure, attend visits as scheduled, and comply with the study requirements; * Subject is male or non-pregnant female; * Subject is deemed to be neuro-psycho-socially appropriate for implantation therapies based of the assessment of a Clinical Psychologist, using face-to-face encounters and the psychological testing described in the measures; * Subject is capable of giving informed consent; * Subject lives within reasonable distance from the study site (circumference of 50 miles). Exclusion Criteria: * Obvious mechanical instability related to pain (diagnosed by imaging taken within the past 6 months); * Unresolved Malignancies in last six months; * Subject has post-herpetic neuralgia (shingles); * Subject has an active systemic infection or is immune-compromised; * Based on the medical opinion of the Principal Investigator, Psychologist and/or Psychiatrist, the subject has other psychological conditions (e.g., psychosis, suicidal ideation, borderline personality disorder, somatization, narcissism), other health conditions (e.g., substance abuse, another chronic condition requiring the regular use of opioid medication), or other legal concerns that would preclude his/her enrollment in the study or potentially confound the results of the study; * Subject is currently enrolled in or plans to enroll in any concurrent drug and/or device study while participating…
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02514590